Although fewer than 20% of participants had an AMH level between 25 and 35 pmol/l in the BEYOND trial, a lower AMH limit of >23 pmol/l can be used to identify women with polycystic ovarian morphology to support a PCOS diagnosis (Dietz de Loos et al., 2021). This evidence concerns the gene AMH and polycystic ovary syndrome.